世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い
 Human Milk Oligosaccharides (HMO) - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Human Milk Oligosaccharides (HMO) was estimated to be worth US$ 708 million in 2024 and is forecast to a readjusted size of US$ 3225 million by 2031 with a CAGR of 24.6% durin... もっと見る
※当ページの内容はウェブ更新時の情報です。
SummaryThe global market for Human Milk Oligosaccharides (HMO) was estimated to be worth US$ 708 million in 2024 and is forecast to a readjusted size of US$ 3225 million by 2031 with a CAGR of 24.6% during the forecast period 2025-2031.Human Milk Oligosaccharides (HMO) are a class of complex carbohydrates naturally found in human breast milk. They are composed of multiple sugar units linked by glycosidic bonds. HMOs are one of the most abundant components in human milk after fat, protein, and lactose, and their concentration is significantly higher in human milk compared to other mammals. HMOs play a crucial role in infant health, serving as prebiotics that promote the growth of beneficial bacteria, such as bifidobacteria, helping to establish a healthy gut microbiome and enhance immune system function. HMOs vary in structure, including monosaccharides, disaccharides, trisaccharides, and longer polysaccharide chains. Different types of HMOs have distinct biological functions, helping to combat pathogen invasion, reduce inflammation, and support brain development. While HMOs are primarily found in human milk, advances in technology have made it possible to extract and synthesize these oligosaccharides through fermentation and chemical processes for use in commercial products like infant formula, functional foods, and health supplements. With ongoing research into the benefits of HMOs in infant health and other wellness applications, the demand for human milk oligosaccharides has been steadily increasing, particularly in infant formula and adult prebiotic foods. Market Development Opportunities and Key Drivers: As consumer awareness of health increases, especially in regard to infant health, the market for human milk oligosaccharides (HMOs) is experiencing significant growth opportunities. In recent years, extensive research on the role of HMOs in infant health has led more infant formula manufacturers to incorporate HMOs into their products to support immune function and gut health. Additionally, HMOs have shown potential in adult health applications, particularly in maintaining gut microbiome balance and enhancing immune function, opening new growth avenues for the market. As the global population ages and the demand for functional foods rises, there is also growing demand for prebiotic products targeting adults. Market Risks: Despite the promising outlook for the HMO market, there are several risks. First, the production of HMOs is complex and costly, which may hinder product accessibility and price competitiveness. Second, the HMO supply chain is intricate, involving multiple stages such as raw material extraction and fermentation. Any technological challenges or disruptions in production could affect the stability of the entire supply chain. Moreover, global regulatory and standard differences may pose challenges to market expansion, particularly in terms of varying regulatory policies and certification requirements in different countries. Market Concentration: Currently, the HMO production market is relatively concentrated, with several leading biotech and pharmaceutical companies dominating the industry. These companies have advanced fermentation and biosynthesis technologies that enable large-scale production while maintaining high quality. However, as technology advances and the market expands, more small and medium-sized enterprises are expected to enter the market, fostering competition and innovation. Downstream Demand Trends: The downstream demand for HMOs is mainly concentrated in infant formula, prebiotic foods and supplements, and personalized nutrition products. As consumers increasingly demand personalized and functional nutrition products, the market for HMOs as a functional ingredient will continue to grow. Additionally, the potential for HMOs in aging populations is being recognized, particularly for supporting gut health and immune systems in elderly individuals. Latest Technologies: The production technology for HMOs is continually evolving, with innovations in fermentation and biosynthesis reducing production costs. Furthermore, the application of genetic engineering and synthetic biology has opened up possibilities for customized HMO production, allowing for optimized efficiency and yields through genetically modified microorganisms. This report aims to provide a comprehensive presentation of the global market for Human Milk Oligosaccharides (HMO), focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Human Milk Oligosaccharides (HMO) by region & country, by Type, and by Application. The Human Milk Oligosaccharides (HMO) market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Human Milk Oligosaccharides (HMO). Market Segmentation By Company Abbott Inbiose Glycom Chr. Hansen (Jennewein) Elicityl SA ZuChem Segment by Type 2'-FL & 3-FL LNT & LNnT, etc. Segment by Application Infant Formula Others By Region North America United States Canada Asia-Pacific China Japan South Korea Southeast Asia India Australia Rest of Asia-Pacific Europe Germany France U.K. Italy Netherlands Nordic Countries Rest of Europe Latin America Mexico Brazil Rest of Latin America Middle East & Africa Turkey Saudi Arabia UAE Rest of MEA Chapter Outline Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry. Chapter 2: Detailed analysis of Human Milk Oligosaccharides (HMO) company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc. Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments. Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets. Chapter 5: Revenue of Human Milk Oligosaccharides (HMO) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world. Chapter 6: Revenue of Human Milk Oligosaccharides (HMO) in country level. It provides sigmate data by Type, and by Application for each country/region. Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc. Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry. Chapter 9: Conclusion. Table of Contents1 Market Overview1.1 Human Milk Oligosaccharides (HMO) Product Introduction 1.2 Global Human Milk Oligosaccharides (HMO) Market Size Forecast (2020-2031) 1.3 Human Milk Oligosaccharides (HMO) Market Trends & Drivers 1.3.1 Human Milk Oligosaccharides (HMO) Industry Trends 1.3.2 Human Milk Oligosaccharides (HMO) Market Drivers & Opportunity 1.3.3 Human Milk Oligosaccharides (HMO) Market Challenges 1.3.4 Human Milk Oligosaccharides (HMO) Market Restraints 1.4 Assumptions and Limitations 1.5 Study Objectives 1.6 Years Considered 2 Competitive Analysis by Company 2.1 Global Human Milk Oligosaccharides (HMO) Players Revenue Ranking (2024) 2.2 Global Human Milk Oligosaccharides (HMO) Revenue by Company (2020-2025) 2.3 Key Companies Human Milk Oligosaccharides (HMO) Manufacturing Base Distribution and Headquarters 2.4 Key Companies Human Milk Oligosaccharides (HMO) Product Offered 2.5 Key Companies Time to Begin Mass Production of Human Milk Oligosaccharides (HMO) 2.6 Human Milk Oligosaccharides (HMO) Market Competitive Analysis 2.6.1 Human Milk Oligosaccharides (HMO) Market Concentration Rate (2020-2025) 2.6.2 Global 5 and 10 Largest Companies by Human Milk Oligosaccharides (HMO) Revenue in 2024 2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Milk Oligosaccharides (HMO) as of 2024) 2.7 Mergers & Acquisitions, Expansion 3 Segmentation by Type 3.1 Introduction by Type 3.1.1 2'-FL & 3-FL 3.1.2 LNT & LNnT, etc. 3.2 Global Human Milk Oligosaccharides (HMO) Sales Value by Type 3.2.1 Global Human Milk Oligosaccharides (HMO) Sales Value by Type (2020 VS 2024 VS 2031) 3.2.2 Global Human Milk Oligosaccharides (HMO) Sales Value, by Type (2020-2031) 3.2.3 Global Human Milk Oligosaccharides (HMO) Sales Value, by Type (%) (2020-2031) 4 Segmentation by Application 4.1 Introduction by Application 4.1.1 Infant Formula 4.1.2 Others 4.2 Global Human Milk Oligosaccharides (HMO) Sales Value by Application 4.2.1 Global Human Milk Oligosaccharides (HMO) Sales Value by Application (2020 VS 2024 VS 2031) 4.2.2 Global Human Milk Oligosaccharides (HMO) Sales Value, by Application (2020-2031) 4.2.3 Global Human Milk Oligosaccharides (HMO) Sales Value, by Application (%) (2020-2031) 5 Segmentation by Region 5.1 Global Human Milk Oligosaccharides (HMO) Sales Value by Region 5.1.1 Global Human Milk Oligosaccharides (HMO) Sales Value by Region: 2020 VS 2024 VS 2031 5.1.2 Global Human Milk Oligosaccharides (HMO) Sales Value by Region (2020-2025) 5.1.3 Global Human Milk Oligosaccharides (HMO) Sales Value by Region (2026-2031) 5.1.4 Global Human Milk Oligosaccharides (HMO) Sales Value by Region (%), (2020-2031) 5.2 North America 5.2.1 North America Human Milk Oligosaccharides (HMO) Sales Value, 2020-2031 5.2.2 North America Human Milk Oligosaccharides (HMO) Sales Value by Country (%), 2024 VS 2031 5.3 Europe 5.3.1 Europe Human Milk Oligosaccharides (HMO) Sales Value, 2020-2031 5.3.2 Europe Human Milk Oligosaccharides (HMO) Sales Value by Country (%), 2024 VS 2031 5.4 Asia Pacific 5.4.1 Asia Pacific Human Milk Oligosaccharides (HMO) Sales Value, 2020-2031 5.4.2 Asia Pacific Human Milk Oligosaccharides (HMO) Sales Value by Region (%), 2024 VS 2031 5.5 South America 5.5.1 South America Human Milk Oligosaccharides (HMO) Sales Value, 2020-2031 5.5.2 South America Human Milk Oligosaccharides (HMO) Sales Value by Country (%), 2024 VS 2031 5.6 Middle East & Africa 5.6.1 Middle East & Africa Human Milk Oligosaccharides (HMO) Sales Value, 2020-2031 5.6.2 Middle East & Africa Human Milk Oligosaccharides (HMO) Sales Value by Country (%), 2024 VS 2031 6 Segmentation by Key Countries/Regions 6.1 Key Countries/Regions Human Milk Oligosaccharides (HMO) Sales Value Growth Trends, 2020 VS 2024 VS 2031 6.2 Key Countries/Regions Human Milk Oligosaccharides (HMO) Sales Value, 2020-2031 6.3 United States 6.3.1 United States Human Milk Oligosaccharides (HMO) Sales Value, 2020-2031 6.3.2 United States Human Milk Oligosaccharides (HMO) Sales Value by Type (%), 2024 VS 2031 6.3.3 United States Human Milk Oligosaccharides (HMO) Sales Value by Application, 2024 VS 2031 6.4 Europe 6.4.1 Europe Human Milk Oligosaccharides (HMO) Sales Value, 2020-2031 6.4.2 Europe Human Milk Oligosaccharides (HMO) Sales Value by Type (%), 2024 VS 2031 6.4.3 Europe Human Milk Oligosaccharides (HMO) Sales Value by Application, 2024 VS 2031 6.5 China 6.5.1 China Human Milk Oligosaccharides (HMO) Sales Value, 2020-2031 6.5.2 China Human Milk Oligosaccharides (HMO) Sales Value by Type (%), 2024 VS 2031 6.5.3 China Human Milk Oligosaccharides (HMO) Sales Value by Application, 2024 VS 2031 6.6 Japan 6.6.1 Japan Human Milk Oligosaccharides (HMO) Sales Value, 2020-2031 6.6.2 Japan Human Milk Oligosaccharides (HMO) Sales Value by Type (%), 2024 VS 2031 6.6.3 Japan Human Milk Oligosaccharides (HMO) Sales Value by Application, 2024 VS 2031 6.7 South Korea 6.7.1 South Korea Human Milk Oligosaccharides (HMO) Sales Value, 2020-2031 6.7.2 South Korea Human Milk Oligosaccharides (HMO) Sales Value by Type (%), 2024 VS 2031 6.7.3 South Korea Human Milk Oligosaccharides (HMO) Sales Value by Application, 2024 VS 2031 6.8 Southeast Asia 6.8.1 Southeast Asia Human Milk Oligosaccharides (HMO) Sales Value, 2020-2031 6.8.2 Southeast Asia Human Milk Oligosaccharides (HMO) Sales Value by Type (%), 2024 VS 2031 6.8.3 Southeast Asia Human Milk Oligosaccharides (HMO) Sales Value by Application, 2024 VS 2031 6.9 India 6.9.1 India Human Milk Oligosaccharides (HMO) Sales Value, 2020-2031 6.9.2 India Human Milk Oligosaccharides (HMO) Sales Value by Type (%), 2024 VS 2031 6.9.3 India Human Milk Oligosaccharides (HMO) Sales Value by Application, 2024 VS 2031 7 Company Profiles 7.1 Abbott 7.1.1 Abbott Profile 7.1.2 Abbott Main Business 7.1.3 Abbott Human Milk Oligosaccharides (HMO) Products, Services and Solutions 7.1.4 Abbott Human Milk Oligosaccharides (HMO) Revenue (US$ Million) & (2020-2025) 7.1.5 Abbott Recent Developments 7.2 Inbiose 7.2.1 Inbiose Profile 7.2.2 Inbiose Main Business 7.2.3 Inbiose Human Milk Oligosaccharides (HMO) Products, Services and Solutions 7.2.4 Inbiose Human Milk Oligosaccharides (HMO) Revenue (US$ Million) & (2020-2025) 7.2.5 Inbiose Recent Developments 7.3 Glycom 7.3.1 Glycom Profile 7.3.2 Glycom Main Business 7.3.3 Glycom Human Milk Oligosaccharides (HMO) Products, Services and Solutions 7.3.4 Glycom Human Milk Oligosaccharides (HMO) Revenue (US$ Million) & (2020-2025) 7.3.5 Glycom Recent Developments 7.4 Chr. Hansen (Jennewein) 7.4.1 Chr. Hansen (Jennewein) Profile 7.4.2 Chr. Hansen (Jennewein) Main Business 7.4.3 Chr. Hansen (Jennewein) Human Milk Oligosaccharides (HMO) Products, Services and Solutions 7.4.4 Chr. Hansen (Jennewein) Human Milk Oligosaccharides (HMO) Revenue (US$ Million) & (2020-2025) 7.4.5 Chr. Hansen (Jennewein) Recent Developments 7.5 Elicityl SA 7.5.1 Elicityl SA Profile 7.5.2 Elicityl SA Main Business 7.5.3 Elicityl SA Human Milk Oligosaccharides (HMO) Products, Services and Solutions 7.5.4 Elicityl SA Human Milk Oligosaccharides (HMO) Revenue (US$ Million) & (2020-2025) 7.5.5 Elicityl SA Recent Developments 7.6 ZuChem 7.6.1 ZuChem Profile 7.6.2 ZuChem Main Business 7.6.3 ZuChem Human Milk Oligosaccharides (HMO) Products, Services and Solutions 7.6.4 ZuChem Human Milk Oligosaccharides (HMO) Revenue (US$ Million) & (2020-2025) 7.6.5 ZuChem Recent Developments 8 Industry Chain Analysis 8.1 Human Milk Oligosaccharides (HMO) Industrial Chain 8.2 Human Milk Oligosaccharides (HMO) Upstream Analysis 8.2.1 Key Raw Materials 8.2.2 Raw Materials Key Suppliers 8.2.3 Manufacturing Cost Structure 8.3 Midstream Analysis 8.4 Downstream Analysis (Customers Analysis) 8.5 Sales Model and Sales Channels 8.5.1 Human Milk Oligosaccharides (HMO) Sales Model 8.5.2 Sales Channel 8.5.3 Human Milk Oligosaccharides (HMO) Distributors 9 Research Findings and Conclusion 10 Appendix 10.1 Research Methodology 10.1.1 Methodology/Research Approach 10.1.1.1 Research Programs/Design 10.1.1.2 Market Size Estimation 10.1.1.3 Market Breakdown and Data Triangulation 10.1.2 Data Source 10.1.2.1 Secondary Sources 10.1.2.2 Primary Sources 10.2 Author Details 10.3 Disclaimer
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野（食品）の最新刊レポート
QYResearch社の 食品・飲料分野 での最新刊レポート
本レポートと同じKEY WORD（milk）の最新刊レポート
よくあるご質問QYResearch社はどのような調査会社ですか?QYリサーチ(QYResearch)は幅広い市場を対象に調査・レポート出版を行う、中国に本社をおく調査会社です。 QYResearchでは年間数百タイトルの調査レポートを出版しています。... もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
|
